Рroblems of diagnostics of dysfunctions of the olfactory analyzer of laboratory animals on the basis of behavioral and electrophysiological methods of research

Cover Page

Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Abstract

Olfactory impairment (decreased acuity, impaired adequate identification of odorants) reduces the quality of life of patients and can be a symptom of a wide range of pathologies of the organism, in particular neurodegenerative processes in the brain. Quantitative measurement of olfactory acuity is necessary for diagnostics of olfactory dysfunctions, monitoring the dynamics of olfaction after pharmacological or surgical treatment. The searching for optimal methods of analyzing olfactory thresholds on animal models of human diseases accompanied by anosmia and comparing them with those in humans seems to be especially urgent problem at the moment. This is necessary for the selection of a valid animal model for the evaluation of new drugs and development the therapy for a wide range of pathologies.

The review analyzes publications devoted to the study of diseases accompanied by anosmia or hyposmia, their zootropic models, and methods of olfactory function assessment. Models for COVID19, Alzheimer’s disease, Parkinson’s disease, diabetes types (1 and 2 type), Kalman syndrome, and Bardet-Biedl syndrome, for which olfactory dysfunction and/or defects of olfactory system are present, were analyzed. The review notes the paucity of data on the measurement of olfactory thresholds in model animals.

Full Text

Restricted Access

About the authors

A. V. Gorskaya

Sechenov Institute of Evolutionary Physiology and Biochemistry of the RAS

Email: dvasilyev@bk.ru
Russian Federation, 194223, Saint Petersburg, Thorez, 44

D. S. Vasilev

Sechenov Institute of Evolutionary Physiology and Biochemistry of the RAS

Author for correspondence.
Email: dvasilyev@bk.ru
Russian Federation, 194223, Saint Petersburg, Thorez, 44

References

  1. Abrams K. L., Ward D. A., Sabiniewicz A., Hummel T. Olfaction evaluation in dogs with sudden acquired retinal degeneration syndrome. Veterinary Ophthalmology. 2023. Epub ahead of print. PMID: 37399129. https://doi.org/10.1111/vop.13121
  2. Andrea X. P., Joceline L. M. Jose O. F. Jose P. O. Human Nasal Epithelium Damage as the Probable Mechanism Involved in the Development of Post-COVID-19 Parosmia. Indian Journal of Otolaryngology and Head & Neck Surgery. 2023. V. 75(1). P. 458—464. https://doi.org/10.1007/s12070—023—03559-x
  3. Aragao M. F. V.V., Leal M. C., Filho O. Q.C., Fonseca T. M., Aragao L. V., Leao M. R.V.C., Valenca M. A., Andrade P. H.P., Aragao J. P.V., Neto S. S.C., Valenca M. M. Comparative study-the impact and profile of COVID-19 patients who are indicated for neuroimaging: vascular phenomena are been found in the brain and olfactory bulbs. Medrxiv. 2021. P. 2020.12.28.20248957. https://doi.org/10.1101/2020.12.28.20248957
  4. Arbuckle E. P., Smith G. D., Gomez M. C., Lugo J. N. Testing for odor discrimination and habituation in mice. Journal of Visualized Experiments. 2015. V. 99. P. e52615. https://doi.org/10.3791/52615
  5. Aydin S., Aksoy A., Aydin S., Kalayci M., Yilmaz M., Kuloglu T., Citil C., Catak Z. Today’s and yesterday’s of pathophysiology: biochemistry of metabolic syndrome and animal models. Nutrition. 2014. V. 30(1). P. 1—9. https://doi.org/10.1016/j.nut.2013.05.013
  6. Baum M. J. Contribution of pheromones processed by the main olfactory system to mate recognition in female mammals. Frontiers in neuroanatomy. 2012. V. 6. P. 20. https://doi.org/10.3389/fnana.2012.00020
  7. Beshel J., Kopell N., Kay L. M. Olfactory bulb gamma oscillations are enhanced with task demands. Journal of Neuroscience. 2007. V. 27(31). P. 8358—8365. https://doi.org/10.1523/JNEUROSCI.1199—07.2007
  8. Boesveldt S., Postma E. M., Boak D., Welge-Luessen A., Schöpf V., Mainland J. D., Martens J., Ngai J., Duffy V. B. Anosmia — a clinical review. Chemical senses. 2017. V. 42(7). P. 513—523. https://doi.org/10.1093/chemse/bjx025
  9. Borghammer P., Just M. K., Horsager J., Skjærbæk C., Raunio A., Kok E. H., Savola S., Murayama S., Saito Y., Myllykangas L., Van Den Berge N. A postmortem study suggests a revision of the dual-hit hypothesis of Parkinson’s disease. NPJ Parkinson’s Disease. 2022. V. 8(1). P. 166. https://doi.org/10.1038/s41531—022—00436—2
  10. Braak H., Braak E. Frequency of stages of Alzheimer-related lesions in different age categories. Neurobiology of aging. 1997. V. 18(4). P. 351—357. https://doi.org/10.1016/S0197—4580(97)00056—0
  11. Braak H., Braak E. Neuropathological stageing of Alzheimer-related changes. Acta neuropathologica. 1991. V. 82(4). P. 239—259. https://doi.org/10.1007/BF00308809
  12. Braak H., Braak E. The human entorhinal cortex: normal morphology and lamina-specific pathology in various diseases. Neuroscience research. 1992. V. 15(1—2). P. 6—31. https://doi.org/10.1016/0168—0102(92)90014—4
  13. Braak H., Del Tredici K., Rüb U., de Vos R. A., Jansen Steur E. N., Braak E. Staging of brain pathology related to sporadic Parkinson’s disease. Neurobiology of aging. 2003. V. 24(2). P. 197—211. https://doi.org/10.1016/S0197—4580(02)00065—9
  14. Bryche B., St Albin A., Murri S., Lacôte S., Pulido C., Ar Gouilh M., Lesellier S., Servat A., Wasniewski M., Picard-Meyer E., Monchatre-Leroy E., Volmer R., Rampin O., Le Goffic R., Marianneau P., Meunier N. Massive transient damage of the olfactory epithelium associated with infection of sustentacular cells by SARS-CoV-2 in golden Syrian hamsters. Brain, behavior, and immunity. 2020. V. 89. P. 579—586. https://doi.org/10.1016/j.bbi.2020.06.032
  15. Butowt R., Bilinska K., von Bartheld C. S. Olfactory dysfunction in COVID-19: New insights into the underlying mechanisms. Trends in Neurosciences. 2023. V. 46(1). P. 75—90. https://doi.org/10.1016/j.tins.2022.11.003
  16. Cave J. W., Fujiwara N., Weibman A. R., Baker H. Cytoarchitectural changes in the olfactory bulb of Parkinson’s disease patients. NPJ Parkinson’s disease. 2016. V. 2(1). P. 1—3. https://doi.org/10.1038/npjparkd.2016.11
  17. Christen-Zaech S., Kraftsik R., Pillevuit O., Kiraly M., Martins R., Khalili K., Miklossy J. Early olfactory involvement in Alzheimer’s disease. Canadian Journal of Neurological Sciences. 2003. V. 30(1). P. 20—25. https://doi.org/10.1017/s0317167100002389
  18. Chu H., Chan J. F.W., Yuen K. Y. Animal models in SARS-CoV-2 research. Nature Methods. 2022. V. 19(4). P. 392—394. https://doi.org/10.1038/s41592—022—01447-w
  19. Cisneros-Larios B., Elias C. F. Sex differences in the coexpression of prokineticin receptor 2 and gonadal steroids receptors in mice. Frontiers in Neuroanatomy. 2023. V. 16. P. 1057727. https://doi.org/10.3389/fnana.2022.1057727
  20. Claire M., Christine, F.N., Terry L. J. Left hippocampal volume loss in Alzheimer’s disease is reflected in performance on odor identification: a structural MRI study. Journal of the International Neuropsychological Society. 2003. V. 9(3). P. 459—471. https://doi.org/10.1017/S1355617703930116
  21. Cooper K. W., Brann D. H., Farruggia M. C., Bhutani S., Pellegrino R., Tsukahara T., Weinreb C., Joseph P. V., Larson E. D., Parma V., Albers M. W., Barlow L. A., Datta S. R., Di Pizio A. COVID-19 and the chemical senses: supporting players take center stage. Neuron. 2020. V. 107(2). P. 219—233. https://doi.org/10.1016/j.neuron.2020.06.032
  22. Coronas-Samano G., Ivanova A. V., Verhagen J. V. The habituation/cross-habituation test revisited: guidance from sniffing and video tracking. Neural plasticity. 2016. V. 2016. https://doi.org/10.1155/2016/9131284
  23. David P., Malkova A. Anosmia in COVID-19 and post-COVID syndrome. Autoimmunity, COVID-19, Post-COVID19 Syndrome and COVID-19 Vaccination. Academic Press. 2023. P. 487—494. https://doi.org/10.1016/B978—0—443—18566—3.00010—4
  24. Davidson T. M., Murphy C., Jalowayski A. A. Smell impairment: can it be reversed? Postgraduate medicine. 1995. V. 98(1). P. 107—118. https://doi.org/10.1080/00325481.1995.11946020
  25. Davis R. E., Swiderski R.E, Rahmouni K., Nishimura D. Y., Mullins R. F., Agassandian K., Philp A. R., Searby C. C., Andrews M. P., Thompson S., Berry C. J., Thedens D. R., Yang B., Weiss R. M., Cassell M. D., Stone E. M., Sheffield V. C. A knockin mouse model of the Bardet–Biedl syndrome 1 M390R mutation has cilia defects, ventriculomegaly, retinopathy, and obesity. Proceedings of the National Academy of Sciences. 2007. V. 104(49). P. 19422—19427. https://doi.org/10.1073/pnas.0708571104
  26. Deer J., Koska J., Ozias M., Reaven P. Dietary models of insulin resistance. Metabolism. 2015. V. 64(2). P. 163—171. https://doi.org/10.1016/j.metabol.2014.08.013
  27. Del Tredici K., Rüb U., De Vos R. A., Bohl J. R., Braak H. Where does Parkinson disease pathology begin in the brain? Journal of Neuropathology & Experimental Neurology. 2002. V. 61(5). P. 413—426. https://doi.org/10.1093/jnen/61.5.413
  28. Di Lullo A. M., Iacotucci P., Comegna M., Amato F., Dolce P., Castaldo G., Cantone E., Carnovale V., Iengo M. Cystic fibrosis: the sense of smell. American Journal of Rhinology & Allergy. 2020. V. 34(1). P. 35—42. https://doi.org/10.1177/1945892419870450
  29. Di Schiavi E., Andrenacci D. Invertebrate models of Kallmann syndrome: molecular pathogenesis and new disease genes. Current genomics. 2013. V. 14(1). P. 2—10. https://doi.org/10.2174/138920213804999174
  30. Doorduijn A. S., de van der Schueren M. A.E., van de Rest O., de Leeuw F. A., Fieldhouse J. L.P., Kester M. I., Teunissen C. E., Scheltens P., van der Flier W. M., Visser M., Boesveldt S. Olfactory and gustatory functioning and food preferences of patients with Alzheimer’s disease and mild cognitive impairment compared to controls: the NUDAD project. Journal of Neurology. 2020. V. 267(1). P. 144—152. https://doi.org/10.1007/s00415—019—09561—0
  31. Dotan A., Muller S., Kanduc D., David P., Halpert G., Shoenfeld Y. The SARS-CoV-2 as an instrumental trigger of autoimmunity. Autoimmunity reviews. 2021. V. 20(4). P. 102792. https://doi.org/10.1016/j.autrev.2021.102792
  32. Doty R. L. Office procedures for quantitative assessment of olfactory function American journal of rhinology. 2007. V. 21(4). P. 460—473. https://doi.org/10.2500/ajr.2007.21.3043
  33. Dubrovskaja N. M., Vasil’ev D.S., Tumanova N. L., Alekseeva O. S., Nalivaeva N. N. Prenatal’naya gipoksiya narushaet obonyatel’nuyu funkciyu v postnatal’nom ontogeneze krys [Prenatal hypoxia disturbs olfactory function in postnatal ontogenesis of rats]. Zhurnal vysshej nervnoj dejatel’nosti im. I. P. Pavlova [I. P. Pavlov Journal of Higher Nervous Activity]. 2021. V. 71(3). P. 415—427 (in Russian). https://doi.org/10.31857/S0044467721030035
  34. Dutta D., Karthik K., Holla V. V., Kamble N., Yadav R., Pal P. K., Mahale R. R. Olfactory bulb volume, olfactory sulcus depth in Parkinson’s disease, atypical parkinsonism. Movement Disorders Clinical Practice. 2023. V. 10(5). P. 794—801. https://doi.org/10.1002/mdc3.13733
  35. Eichers E. R., Paylor R., Lewis R. A., Bi W., Lin X., Meehan T. P., Stockton D. W., Justice M. J., Lupski J. R. Phenotypic characterization of Bbs4 null mice reveals age-dependent penetrance and variable expressivity. Human genetics. 2006. V. 120. P. 211—226. https://doi.org/10.1007/s00439—006—0197-y
  36. Ellrichmann G., Blusch A., Fatoba O., Brunner J., Reick C., Hayardeny L., Hayden M., Sehr D., Winklhofer K. F., Saft C., Gold R. Laquinimod treatment in the R6/2 mouse model. Scientific reports. 2017. V. 7(1). P. 4947. https://doi.org/10.1038/s41598—017—04990—1
  37. Falkowski B., Chudziński M., Jakubowska E., Duda-Sobczak A. Association of olfactory function with the intensity of self-reported physical activity in adults with type 1 diabetes. Pol Arch Intern Med. 2017. V. 127(7—8). P. 476—80. https://doi.org/10.20452/pamw.4073
  38. Fan C., Wu Y., Rui X., Yang Y., Ling C., Liu S., Liu S., Wang Y. Animal models for COVID-19: advances, gaps and perspectives. Signal Transduction and Targeted Therapy. 2022. V. 7(1). P. 220. https://doi.org/10.1038/s41392—022—01087—8
  39. Fiani B., Quadri S. A., Cathel A., Farooqui M., Ramachandran A., Siddiqi I., Ghanchi H., Zafar A., Berman B. W., Siddiqi J. Esthesioneuroblastoma: a comprehensive review of diagnosis, management, and current treatment options. World neurosurgery. 2019. V. 126. P. 194—211. https://doi.org/10.1016/j.wneu.2019.03.014
  40. Flores-Cuadrado A., Saiz-Sanchez D., Mohedano-Moriano A., Lamas-Cenjor E., Leon-Olmo V., Martinez-Marcos A., Ubeda-Bañon I. Astrogliosis and sexually dimorphic neurodegeneration and microgliosis in the olfactory bulb in Parkinson’s disease. NPJ Parkinson’s Disease. 2021. V. 7(1). P. 11. https://doi.org/10.1038/s41531—020—00154—7
  41. Franks K. H., Chuah M. I., King A. E., Vickers J. C. Connectivity of pathology: the olfactory system as a model for network-driven mechanisms of Alzheimer’s disease pathogenesis. Frontiers in aging neuroscience. 2015. V. 7. P. 234. https://doi.org/10.3389/fnagi.2015.00234
  42. Fujita M., Ho G., Takamatsu Y., Wada R., Ikeda K., Hashimoto M. Possible Role of Amyloidogenic Evolvability in Dementia with Lewy Bodies: Insights from Transgenic Mice Expressing P123H -Synuclein. International Journal of Molecular Sciences. 2020. V. 21(8). P. 2849. https://doi.org/10.3390/ijms21082849
  43. Gascón C., Santaolalla F., Martínez A., Sánchez Del Rey A. Usefulness of the BAST-24 smell and taste test in the study of diabetic patients: a new approach to the determination of renal function. Acta oto-laryngologica. 2013. V. 133(4). P. 400—404. https://doi.org/10.3109/00016489.2012.746471
  44. Gaudel F., Stephan D., Landel V., Sicard G., Féron F., Guiraudie-Capraz G. Expression of the Cerebral Olfactory Receptors Olfr110/111 and Olfr544 Is Altered During Aging and in Alzheimer’s Disease-Like Mice. Mol Neurobiol 2018. V. 56. P. 2057—2072. https://doi.org/10.1007/s12035—018—1196—4
  45. Gawenis L. R., Hodges C. A., McHugh D.R., Valerio D. M., Miron A., Cotton C. U., Liu J., Walker N. M., Strubberg A. M., Gillen A. E., Mutolo M. J., Kotzamanis G., Bosch J., Harris A., Drumm M. L., Clarke L. L. A BAC transgene expressing human CFTR under control of its regulatory elements rescues CFTR knockout mice. Scientific Reports. 2019. V. 9(1). P. 11828. https://doi.org/10.1038/s41598—019—48105—4
  46. Gheusi G. Behavioral Methods in Olfactory Research. Encyclopedia of Neuroscience. Berlin, Heidelberg. Springer, 2008. 4398 p. https://doi.org/10.1007/978—3—540—29678—2_590
  47. Gouveri E., Katotomichelakis M., Gouveris H., Danielides V., Maltezos E., Papanas N. Olfactory dysfunction in type 2 diabetes mellitus: an additional manifestation of microvascular disease? Angiology. 2014. V. 65(10). P. 869—876. https://doi.org/10.1177/0003319714520956
  48. Gruber A. D., Firsching T. C., Trimpert J., Dietert K. Hamster models of COVID-19 pneumonia reviewed: How human can they be? Veterinary Pathology. 2022. V. 59(4). P. 528—545. https://doi.org/10.1177/03009858211057197
  49. Guilbault C., Saeed Z., Downey G. P., Radzioch D. Cystic fibrosis mouse models. American journal of respiratory cell and molecular biology. 2007. V. 36(1). P. 1—7. https://doi.org/10.1165/rcmb.2006—0184TR
  50. Gvazava I. G., Karimova M. V., Vasil’ev A.V., Voroteljak E. A. Saharnyj diabet 2 tipa: osobennosti patogeneza i jeksperimental’nye modeli na gryzunah [Type 2 diabetes mellitus: pthogenic features and experimental models in rodents]. Acta Naturae [Acta Naturae]. 2022. V. 14(3). P. 57—68 (in Russian). https://doi.org/10.32607/actanaturae.11751
  51. Hardy J., Selkoe D. J. The amyloid hypothesis of Alzheimer’s disease: progress and problems on the road to therapeutics. Science. 2002. V. 297. P. 353—356. https://doi.org/10.1126/science.1072994
  52. Howe de la Torre S., Parlatini V., Cortese S. Long-term central nervous system (CNS) consequences of COVID-19 in children. Expert Review of Neurotherapeutics. 2023. V. 23(8). P. 703—720. https://doi.org/10.1080/14737175.2023.2239500
  53. Hubbard P. S., Esiri M. M., Reading M., McShane R., Nagy Z. Alpha‐synuclein pathology in the olfactory pathways of dementia patients. Journal of anatomy. 2007. V. 211(1). P. 117—124. https://doi.org/10.1111/j.1469—7580.2007.00748.x
  54. Hudson M. L., Kinnunen T., Cinar H. N., Chisholm A. D. C. elegans Kallmann syndrome protein KAL-1 interacts with syndecan and glypican to regulate neuronal cell migrations. Developmental biology. 2006. V. 294(2). P. 352—365. https://doi.org/10.1016/j.ydbio.2006.02.036
  55. Huisman E., Uylings H. B.M., Hoogland P. V. A 100% increase of dopaminergic cells in the olfactory bulb may explain hyposmia in Parkinson’s disease. Movement disorders. 2004. V. 19(6). P. 687—692. https://doi.org/10.1002/mds.10713
  56. Huisman E., Uylings H. B.M., Hoogland P. V. Gender‐related changes in increase of dopaminergic neurons in the olfactory bulb of Parkinson’s disease patients. Movement disorders: official journal of the Movement Disorder Society. 2008. V. 23(10). P. 1407—1413. https://doi.org/10.1002/mds.22009.
  57. Hummel T., Liu D. T., Müller C. A., Stuck B. A., Welge-Lüssen A., Hähner A. Olfactory Dysfunction: Etiology, Diagnosis, and Treatment. Deutsches Ärzteblatt International. 2023. V. 120(9). P. 146. https://doi.org/10.3238/arztebl.m2022.0411
  58. Hüttenbrink K. B., Hummel T., Berg D., Gasser T., Hähner A. Olfactory dysfunction: common in later life and early warning of neurodegenerative disease. Deutsches Ärzteblatt International. 2013. V. 110(1—2). P. 1. https://doi.org/10.3238/arztebl.2013.0001
  59. Iptyshev A. M., Gorina Ja.V., Lopatina O. L., Komleva Ju.K., Salmina A. B. Jeksperimental’nye modeli bolezni Al’cgejmera: preimushhestva i nedostatki [Experimental models of Alzheimer’s disease: advantages and disadvantages]. Sibirskoe medicinskoe obozrenie [Siberian Medical Review]. 2016. V. 4(100). P. 5—21 (in Russian).
  60. Ishimaru T., Miwa T., Nomura M., Iwato M., Furukawa M. Reversible hyposmia caused by intracranial tumour. The Journal of Laryngology & Otology. 1999. V. 113(8). P. 750—753. https://doi.org/10.1017/s0022215100145104
  61. Jacobsen J. S., Wu C. C., Redwine J. M., Comery T. A., Arias R., Bowlby M., Martone R., Morrison J. H., Pangalos M. N., Reinhart P. H., Bloom F. E. Early-onset behavioral and synaptic deficits in a mouse model of Alzheimer’s disease. Proc Natl Acad Sci USA. 2006. V.103(13). P. 5161—6. doi: 10.1073/pnas.0600948103.
  62. Jamain S., Radyushkin K., Hammerschmidt K., Granon S., Boretius S., Varoqueaux F., Ramanantsoa N., Gallego J., Ronnenberg A., Winter D., Frahm J., Fischer J., Bourgeron T., Ehrenreich H., Brose N. Reduced social interaction and ultrasonic communication in a mouse model of monogenic heritable autism. Proceedings of the National Academy of Sciences. 2008. V. 105(5). P. 1710—1715. https://doi.org/10.1073/pnas.0711555105
  63. Jimenez, R.C., Casajuana-Martin, N., García-Recio, A. Alcántara L., Pardo L., Campillo M., Gonzalez F. The mutational landscape of human olfactory G protein-coupled receptors. BMC Biol. 2021. V. 19. P. 21. doi: 10.1186/s12915—021—00962—0
  64. Jiménez A., Organista-Juárez D., Torres-Castro A., Guzmán-Ruíz M.A, Estudillo E., Guevara-Guzmán R. Olfactory dysfunction in diabetic rats is associated with miR-146a overexpression and inflammation. Neurochemical Research. 2020. V. 45(8). P. 1781—1790. https://doi.org/10.1007/s11064—020—03041-y
  65. Jing Y., Qi C. C., Yuan L., Liu X. W., Gao L. P., Yin J. Adult neural stem cell dysfunction in the subventricular zone of the lateral ventricle leads to diabetic olfactory defects. Neural Regeneration Research. 2017. V. 12(7). P. 1111—1118. https://doi.org/10.4103/1673—5374.211190
  66. King A. J.F. The use of animal models in diabetes research. British Journal of Pharmacology. 2012. V. 166(3). P. 877—894. https://doi.org/10.1111/j.1476—5381.2012.01911.x
  67. Kiroj V. N., Kosenko P. O., SHaposhnikov P.D., Aslanyan E. V., Saevskij A. I. Izmenenie spektral’nyh harakteristik i urovnya kogerentnosti fokal’noj aktivnosti obonyatel’noj lukovicy krysy v dinamike ksilazin-tiletaminzolazepamovogo narkoza [Changes in the spectral characteristics and level of coherence of the focal activity of the rat olfactory bulb in the dynamics of xylazine-tiletaminzolazepam anesthesia] Sensornye Sistemy [Sensory systems]. 2023. V. 37(1). P. 65—77 (in Russian). https://doi.org/10.31857/S0235009223010043
  68. Kohn D. F., Clifford C. B. Biology and diseases of rats. Laboratory animal medicine. 2002. P. 121—165. https://doi.org/10.1016/B978—012263951—7/50007—7
  69. Konnova E. A., Swanberg M. Animal models of Parkinson’s disease. Parkinson’s Disease: Pathogenesis and Clinical Aspects. Brisbane. Exon Publications. 2018. P. 83—106. https://doi.org/10.15586/codonpublications.parkinsonsdisease.2018.ch5
  70. Kosenko P. O., Smolikov A. B., Voynov V. B., Shaposhnikov P. D., Saevskiy A. I., Kiroy V. N. Effect of Xylazine-Tiletamine-Zolazepam on the Local Field Potential of the Rat Olfactory Bulb. Comp Med. 2020. V. 70(6). P. 492—498.
  71. https://doi.org/10.30802/AALAS-CM-20—990015.
  72. Kretschmer V., Patnaik S. R., Kretschmer F., Chawda M. M., Hernandez-Hernandez V., May-Simera H. L. Progressive characterization of visual phenotype in Bardet-Biedl syndrome mutant mice. Investigative Ophthalmology & Visual Science. 2019. V. 60(4). P. 1132—1143. https://doi.org/10.1167/iovs.18—25210
  73. Kulaga H. M., Patnaik S. R., Kretschmer F., Chawda M. M., Hernandez-Hernandez V., May-Simera H. L. Loss of BBS proteins causes anosmia in humans and defects in olfactory cilia structure and function in the mouse. Nature genetics. 2004. V. 36(9). P. 994—998. https://doi.org/10.1038/ng1418
  74. Le Floch J. P., Le Lièvre G., Labroue M., Paul M., Peynegre R., Perlemuter L. et al. Smell dysfunction and related factors in diabetic patients. Diabetes care. 1993. V. 16.(6). P. 934—937. https://doi.org/10.2337/diacare.16.6.934
  75. Le Pichon C. E., Valley M.T, Polymenidou M., Chesler A. T., Sagdullaev B. T., Aguzzi A., Firestein S. Olfactory behavior and physiology are disrupted in prion protein knockout mice. Nature neuroscience. 2009. V. 12(1). P. 60—69. https://doi.org/10.1038/nn.2238
  76. Lewis J., Dickson D. W., Lin W. L., Chisholm L., Corral A., Jones G., Yen S. H., Sahara N., Skipper L., Yager D., Eckman C., Hardy J., Hutton M., McGowan E. Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP. Science. 2001. V. 293. P. 1487—1491. https://doi.org/10.1126/science.1058189
  77. Li F., Ponissery-Saidu S., Yee K. K., Wang H., Chen M. L., Iguchi N., Zhang G., Jiang P., Reisert J., Huang L. Heterotrimeric G protein subunit G13 is critical to olfaction. Journal of Neuroscience. 2013. V. 33(18). P. 7975—7984. https://doi.org/10.1523/JNEUROSCI.5563—12.2013
  78. Li J., Gu C. Z., Su J. B., Zhu L. H., Zhou Y., Huang H. Y., Liu C. F. Changes in olfactory bulb volume in Parkinson’s disease: a systematic review and meta-analysis. PLoS One. 2016. V. 11. (2). P. e0149286. https://doi.org/10.1371/journal.pone.0149286
  79. Lietzau G., Davidsson W., Östenson C. G., Chiazza F., Nathanson D., Pintana H., Skogsberg J., Klein T., Nyström T., Darsalia V., Patrone C. Type 2 diabetes impairs odour detection, olfactory memory and olfactory neuroplasticity; effects partly reversed by the DPP-4 inhibitor Linagliptin. Acta neuropathologica communications. 2018. V. 6. P. 1—15. https://doi.org/10.1186/s40478—018—0517—1
  80. Luo A. H., Cannon E. H., Wekesa K. S., Lyman R. F., Vandenbergh J. G., Anholt R. R. Impaired olfactory behavior in mice deficient in the  subunit of Go. Brain research. 2002. V. 941(1—2). P. 62—71. https://doi.org/10.1016/s0006—8993(02)02566—0
  81. Machado C. F., Reis-Silva T.M., Lyra C. S., Felicio L. F., Malnic B. Buried food-seeking test for the assessment of olfactory detection in mice. Bio-protocol. 2018. V. 8(12). P. e2897–e2897. https://doi.org/10.21769/BioProtoc.2897
  82. Macknin J. B., Higuchi M., Lee V. M., Trojanowski J. Q., Doty R. L. Olfactory dysfunction occurs in transgenic mice overexpressing human  protein. Brain research. 2004. V. 1000(1—2). P. 174—178. https://doi.org/10.1016/j.brainres.2004.01.047
  83. Mai Y., Klockow M., Haehner A., Hummel T. Self-assessment of olfactory function using the “Sniffin’Sticks”. European Archives of Oto-Rhino-Laryngology. 2023. V. 280(8). P. 1—13. https://doi.org/10.1007/s00405—023—07872—7
  84. Manan H. A., Yahya N., Han P., Hummel T. A. A systematic review of olfactory-related brain structural changes in patients with congenital or acquired anosmia. Brain Structure and Function. 2022. V. 227(1). P. 1—26. https://doi.org/10.1007/s00429—021—02397—3
  85. Mariman E. C., Vink R. G., Roumans N. J., Bouwman F. G., Stumpel C. T., Aller E. E., van Baak M. A., Wang P. The cilium: a cellular antenna with an influence on obesity risk. British Journal of Nutrition. 2016. V. 116(4). P. 576—592. https://doi.org/10.1017/S0007114516002282
  86. Martin C., Gervais R., Hugues E., Messaoudi B., Ravel N. Learning Modulation of Odor-Induced Oscillatory Responses in the Rat Olfactory Bulb: A Correlate of Odor Recognition. J. Neurosci. 2004. V. 24. P. 389—397. https://doi.org/10.1523/JNEUROSCI.3433—03.2004
  87. Masurkar A. V., Devanand D. P. Olfactory dysfunction in the elderly: basic circuitry and alterations with normal aging and Alzheimer’s disease. Current geriatrics reports. 2014. V. 3. P. 91—100. https://doi.org/10.1007/s13670—014—0080-y
  88. Mathis S., Le Masson G., Soulages A., Duval F., Carla L., Vallat J. M., Solé G. Olfaction and anosmia: From ancient times to COVID-19. Journal of the Neurological Sciences. 2021. V. 425. P. 117433. https://doi.org/10.1016/j.jns.2021.117433
  89. Mayer S. K., Thomas J., Helms M., Kothapalli A., Cherascu I., Salesevic A., Stalter E., Wang K., Datta P., Searby C., Seo S., Hsu Y., Bhattarai S., Sheffield V. C., Drack A. V. Progressive retinal degeneration of rods and cones in a Bardet-Biedl syndrome type 10 mouse model. Disease Models & Mechanisms. 2022. V. 15(9). P. dmm049473. https://doi.org/10.1242/dmm.049473
  90. McCarron A., Parsons D., Donnelley M. Animal and cell culture models for cystic fibrosis: which model is right for your application? The American Journal of Pathology. 2021. V. 191(2). P. 228—242. https://doi.org/10.1016/j.ajpath.2020.10.017
  91. McHugh D.R., Steele M. S., Valerio D. M., Miron A., Mann R. J., LePage D.F., Conlon R. A., Cotton C. U., Drumm M. L., Hodges C. A. A G542X cystic fibrosis mouse model for examining nonsense mutation directed therapies. PLoS One. 2018. V. 13(6). P. e0199573. https://doi.org/10.1371/journal.pone.0199573
  92. McShane R.H., Nagy Z., Esiri M. M., King E., Joachim C., Sullivan N., Smith A. D. Anosmia in dementia is associated with Lewy bodies rather than Alzheimer’s pathology. Journal of Neurology, Neurosurgery & Psychiatry. 2001. V. 70(6). P. 739—743. https://doi.org/10.1136/jnnp.70.6.739
  93. Melluso A., Secondulfo F., Capolongo G., Capasso G., Zacchia M. Bardet-Biedl Syndrome: Current Perspectives and Clinical Outlook. Therapeutics and Clinical Risk Management. 2023. V. 19. P. 115—132. https://doi.org/10.2147/TCRM.S338653.
  94. Meredith T. L., Caprio J., Kajiura S. M. Sensitivity and specificity of the olfactory epithelia of two elasmobranch species to bile salts. J. Exp. Biol. 2012. V. 215. P. 2660—2667. https://doi.org/10.1242/jeb.066241
  95. Mitrano D. A., Houle S. E., Pearce P., Quintanilla R. M., Lockhart B. K., Genovese B. C., Schendzielos R. A., Croushore E. E., Dymond E. M., Bogenpohl J. W., Grau H. J., Webb L. S. Olfactory dysfunction in the 3xTg-AD model of Alzheimer’s disease. IBRO Neuroscience Reports. 2021. V. 10. P. 51—61. https://doi.org/10.1016/j.ibneur.2020.12.004
  96. Morozova S. V., Savvateeva D. M., Petrova E. I. Obonjatel’nye rasstrojstva u pacientov s nejrodegenerativnymi zabolevanijami [Olfactory disorders in patients with neurodegenerative diseases]. Nevrologicheskij zhurnal [Neurological journal]. 2014. V. 19(1). P. 4—8 (in Russian).
  97. Mundiñano I.C, Caballero M. C., Ordóñez C., Hernandez M., DiCaudo C., Marcilla I., Erro M. E., Tuñon M. T., Luquin M. R. Increased dopaminergic cells and protein aggregates in the olfactory bulb of patients with neurodegenerative disorders. Acta neuropathologica. 2011. V. 122. P. 61—74. https://doi.org/10.1007/s00401—011—0830—2
  98. Murcia-Belmonte V., Tercero-Díaz M., Barrasa-Martín D., López de la Vieja S., Muñoz-López M., Esteban P. F. Anosmin 1 N-terminal domains modulate prokineticin receptor 2 activation by prokineticin 2. Cellular Signalling. 2022. V. 98. P. 110417. https://doi.org/10.1016/j.cellsig.2022.110417
  99. Murphy C. Olfactory and other sensory impairments in Alzheimer disease. Nature Reviews Neurology. 2019. V. 15(1). P. 11—24. https://doi.org/10.1038/s41582—018—0097—5
  100. Nakazawa A., Nakazawa H., Kaji S., Ishii S. Oscillatory Electric Potential on the Olfactory Epithelium Observed during the Breeding Migration Period in the Japanese Toad, Bufo japonicus. Zoological Sciences. 2000. V. 17. P. 293—300.
  101. https://doi.org/10.2108/jsz.17.293
  102. Neff E. P. A natural macaque model of Bardet-Biedl appears in Oregon. Lab. Animal. 2020. V. 49(1). P. 17—17. https://doi.org/10.1038/s41684—019—0449—9
  103. Neuner S. M., Heuer S. E., Huentelman M. J., O’Connell K.M.S., Kaczorowski C. C. Harnessing genetic complexity to enhance translatability of Alzheimer’s disease mouse models: a path toward precision medicine. Neuron. 2019. V. 101(3). P. 399—411. e5. https://doi.org/10.1016/j.neuron.2018.11.040
  104. Nigro P., Chiappiniello A., Simoni S., Paolini Paoletti F., Cappelletti G., Chiarini P., Filidei M., Eusebi P., Guercini G., Santangelo V., Tarducci R., Calabresi P., Parnetti L., Tambasco N. Changes of olfactory tract in Parkinson’s disease: a DTI tractography study. Neuroradiology. 2021. V. 63. P. 235—242. https://doi.org/10.1007/s00234—020—02551—4
  105. Nishimura D. Y., Fath M., Mullins R. F., Searby C., Andrews M., Davis R., Andorf J. L., Mykytyn K., Swiderski R. E., Yang B., Carmi R., Stone E. M., Sheffield V. C. Bbs2-null mice have neurosensory deficits, a defect in social dominance, and retinopathy associated with mislocalization of rhodopsin. Proceedings of the National Academy of Sciences. 2004. V. 101(47). P. 16588—16593. https://doi.org/101 (47) 16588—16593
  106. Nosulia E. V., Kim I. A., Borisenko G. N., Chernykh N. M., Shpakova E. A. Obonyatel’naya disfunkciya v praktike otorinolaringologa: analiz simptomov pri razlichnyh patologicheskih sostoyaniyah i u beremennyh [Olfactory dysfunction encountered in the practical work of the otorhinolaryngologist: the analysis of symptoms of different pathological conditions and in the pregnant women]. Vestnik Oto-Rino-Laringologii [Bulletin of Otorhinolaryngology]. 2013. V. 78(4). P. 72—77 (in Russian).
  107. Oakley H., Cole S. L., Logan S., Maus E., Shao P., Craft J., Guillozet-Bongaarts A., Ohno M., Disterhoft J., Van Eldik L., Berry R., Vassar R. Intraneuronal -amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer’s disease mutations: potential factors in amyloid plaque formation. Journal of Neuroscience. 2006. V. 26(40). P. 10129—10140. https://doi.org/10.1523/JNEUROSCI.1202—06.2006
  108. Oddo S., Caccamo A., Shepherd J. D., Murphy M. P., Golde T. E., Kayed R., Metherate R., Mattson M. P., Akbari Y., LaFerla F. M. Triple-transgenic model of Alzheimer’s disease with plaques and tangles: intracellular A and synaptic dysfunction. Neuron. 2003. V. 39(3). P. 409—421. https://doi.org/10.1016/s0896—6273(03)00434—3
  109. Olichney J. M., Murphy C., Hofstetter C. R., Foster K., Hansen L. A., Thal L. J., Katzman R. Anosmia is very common in the Lewy body variant of Alzheimer’s disease. Journal of Neurology, Neurosurgery & Psychiatry. 2005. V. 76(10). P. 1342—1347. https://doi.org/10.1136/jnnp.2003.032003
  110. Pak T. K., Carter C. S., Zhang Q., Huang S. C., Searby C., Hsu Y., Taugher R. J., Vogel T., Cychosz C. C., Genova R., Moreira N. N., Stevens H., Wemmie J. A., Pieper A. A., Wang K., Sheffield V. C. A mouse model of Bardet-Biedl Syndrome has impaired fear memory, which is rescued by lithium treatment. PLoS genetics. 2021. V. 17(4). P. e1009484. https://doi.org/10.1371/journal.pgen.1009484
  111. Pashkevich S. G., Eremenko Ju.E., Mironova G. P., Gladkova Zh.A., Andrianova T. D., Tokal’chik D.P., Rjabceva S. N., Derevjanko I. A., Stukach Ju.P., Kul’chickij V. A. Jeksperimental’naja model’ aspirinovoj triady [Experimental model of the Samter’s triad]. Otorinolaringologija. Vostochnaja Evropa [Otorhinolaryngology. Eastern Europe]. 2015. V. 3. P. 58—62 (in Russian).
  112. Patino J., Karagas N. E., Chandra S., Thakur N., Stimming E. F. Olfactory dysfunction in Huntington’s disease. Journal of Huntington’s disease. 2021. V. 10(4). P. 413—422. https://doi.org/10.3233/JHD-210497
  113. Patt Y. S., Fisher L., David P., Bergwerk M., Shoenfeld Y. Autoimmunity, COVID-19 Omicron Variant, and Olfactory Dysfunction: A Literature Review. Diagnostics. 2023. V. 13(4). P. 641. https://doi.org/10.3390/diagnostics13040641
  114. Pearce R. K.B., Hawkes C. H., Daniel S. E. The anterior olfactory nucleus in Parkinson’s disease. Movement disorders: official journal of the Movement Disorder Society. 1995. V. 10(3). P. 283—287. https://doi.org/10.1002/mds.870100309
  115. Peterson S. M., McGill T.J., Puthussery T., Stoddard J., Renner L., Lewis A. D., Colgin L. M.A., Gayet J., Wang X., Prongay K., Cullin C., Dozier B. L., Ferguson B., Neuringer M. Bardet-Biedl Syndrome in rhesus macaques: A nonhuman primate model of retinitis pigmentosa. Experimental eye research. 2019. V. 189. P. 107825. https://doi.org/10.1016/j.exer.2019.107825
  116. Piiponniemi T. O., Parkkari T., Heikkinen T., Puoliväli J., Park L. C., Cachope R., Kopanitsa M. V. Impaired performance of the Q175 mouse model of Huntington’s disease in the touch screen paired associates learning task. Frontiers in Behavioral Neuroscience. 2018. V. 12. P. 226. https://doi.org/10.3389/fnbeh.2018.00226
  117. Pouladi M. A., Morton A. J., Hayden M. R. Choosing an animal model for the study of Huntington’s disease. Nature Reviews Neuroscience. 2013. V. 14(10). P. 708—721. https://doi.org/10.1038/nrn3570
  118. Prediger R. D., Aguiar A. S. Jr, Rojas-Mayorquin A.E., Figueiredo C. P., Matheus F. C., Ginestet L., Chevarin C., Bel E. D., Mongeau R., Hamon M., Lanfumey L., Raisman-Vozari R. Single intranasal administration of 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine in C57BL/6 mice models early preclinical phase of Parkinson’s disease. Neurotoxicity research. 2010. V. 17. P. 114—129. https://doi.org/10.1007/s12640—009—9087—0
  119. Rasmussen V. F., Rasmussen D., Thrysøe M., Karlsson P., Madsen M., Kristensen K., Nyengaard J. R., Terkelsen A. J., Vestergaard E. T., Ovesen T. Cranial Nerve Affection in Adolescents with Type 1 Diabetes Assessed by Corneal Confocal Microscopy, Smell and Taste Tests. Pediatric Diabetes. 2023. V. 2023. P. 2709361. https://doi.org/10.1155/2023/2709361
  120. Rödig N., Sellmann K., Dos Santos Guilherme M., Nguyen V. T.T., Cleppien D., Stroh A., May-Simera H.L., Endres K. Behavioral Phenotyping of Bbs6 and Bbs8 Knockout Mice Reveals Major Alterations in Communication and Anxiety. International Journal of Molecular Sciences. 2022. V. 23. P. 14506. https://doi.org/10.3390/ijms232314506
  121. Rodríguez-Jiménez J.C., Moreno-Paz F.J., Terán L. M., Guaní-Guerra E. Aspirin exacerbated respiratory disease: current topics and trends. Respiratory medicine. 2018. V. 135. P. 62—75. https://doi.org/10.1016/j.rmed.2018.01.002
  122. Rolen, S.H., Caprio, J. Bile salts are effective taste stimuli in channel catfish. J. Exp. Biol. 2008. V. 211. P. 2786—2791. https://doi.org/10.1242/jeb.018648
  123. Rosen B. H., Chanson M., Gawenis L. R., Liu J., Sofoluwe A., Zoso A., Engelhardt J. F. Animal and model systems for studying cystic fibrosis. Journal of Cystic Fibrosis. 2018. V. 17(2). P. S28–S34. https://doi.org/10.1016/j.jcf.2017.09.001
  124. Rugarli E. I., Di Schiavi E., Hilliard M. A., Arbucci S., Ghezzi C., Facciolli A., Coppola G., Ballabio A., Bazzicalupo P. The Kallmann syndrome gene homolog in C. elegans is involved in epidermal morphogenesis and neurite branching. Development and Deseases 2002. V.129(5). P. 1283—1294. https://doi.org/10.1242/dev.129.5.1283
  125. Schmachtenberg O. Histological and electrophysiological properties of crypt cells from the olfactory epithelium of the marine teleost Trachurus symmetricus. J Comp Neurol 2006. V. 495(1). P. 113—121. https://doi.org/10.1002/cne.20847
  126. Shu M., Wu H., Wei S., Shi Y., Li Z., Cheng Y., Fang L., Xu C. Identification and Functional Characterization of a Novel Variant in the SEMA3A Gene in a Chinese Family with Kallmann Syndrome. International Journal of Endocrinology. 2022. V. 2022. P. 2504660. https://doi.org/10.1155/2022/2504660
  127. Slotnick B., Coppola D. M. Odor-cued taste avoidance: a simple and robust test of mouse olfaction. Chemical Senses. 2015. V. 40(4). P. 269—278. https://doi.org/10.1093/chemse/bjv005
  128. Spielman D. B., Overdevest J., Gudis D. A. Olfactory outcomes in the management of aspirin exacerbated respiratory disease related chronic rhinosinusitis. World Journal of Otorhinolaryngology-Head and Neck Surgery. 2020. V. 6(4). P. 207—213. https://doi.org/10.1016/j.wjorl.2020.07.001
  129. Su C. Y., Menuz K., Carlson J. R. Olfactory perception: receptors, cells, and circuits. Cell. 2009. V. 139(1). P. 45—59. https://doi.org/10.1016/j.cell.2009.09.015
  130. Taguchi T., Ikuno M., Hondo M., Parajuli L. K., Taguchi K., Ueda J., Sawamura M., Okuda S., Nakanishi E., Hara J., Uemura N., Hatanaka Y., Ayaki T., Matsuzawa S., Tanaka M., El-Agnaf O.M.A., Koike M., Yanagisawa M., Uemura M. T., Yamakado H., Takahashi R. -Synuclein BAC transgenic mice exhibit RBD-like behaviour and hyposmia: a prodromal Parkinson’s disease model. Brain. 2020. V. 143(1). P. 249—265. https://doi.org/10.1093/brain/awz380
  131. Taniguchi M., Mitsui C., Hayashi H., Ono E., Kajiwara K., Mita H., Watai K., Kamide Y., Fukutomi Y., Sekiya K., Higashi N. Aspirin-exacerbated respiratory disease (AERD): Current understanding of AERD. Allergology International. 2019. V. 68(3). P. 289—295. https://doi.org/10.1016/j.alit.2019.05.001
  132. Tarakad A., Jankovic J. Anosmia and ageusia in Parkinson’s disease. International review of neurobiology. 2017. V. 133. P. 541—556. https://doi.org/10.1016/bs.irn.2017.05.028
  133. Tchekmedyian R., Lundberg M., Buchheit K. M., Maurer R., Gakpo D., Mullur J., Bensko J. C., Laidlaw T. M. Loss of smell in patients with aspirin‐exacerbated respiratory disease impacts mental health and quality of life. Clinical & Experimental Allergy. 2022. V. 52(12). P. 1414—1421. https://doi.org/10.1111/cea.14157
  134. Tiganov A. S., Snezhnevskij A. V., Orlovskaja D. D. i dr. Rukovodstvo po psihiatrii T. 1 [Guide to Psychiatry V. 1] Moscow. Medicina, 1999. 712 p. (in Russian).
  135. Torres-Pasillas G., Chi-Castañeda D., Carrillo-Castilla P., Marín G., Hernández-Aguilar M.E., Aranda-Abreu G.E., Manzo J., García L. I. Olfactory Dysfunction in Parkinson’s Disease, Its Functional and Neuroanatomical Correlates. NeuroSci. 2023. V. 4(2). P. 134—151. https://doi.org/10.3390/neurosci4020013
  136. Tricas, T.C., Kajiura, S.M., Summers, A. P. Response of the hammerhead shark olfactory epithelium to amino acid stimuli. J. Comp. Physiol. 2009. V 195. P. 947—954. https://doi.org/10.1007/s00359—009—0470—3
  137. Van Raamsdonk J. M., Warby S. C., Hayden M. R. Selective degeneration in YAC mouse models of Huntington disease. Brain research bulletin. 2007. V. 72(2—3). P. 124—131. https://doi.org/10.1016/j.brainresbull.2006.10.018.
  138. Várkonyi T., Körei A., Putz Z., Kempler P. Olfactory dysfunction in diabetes: a further step in exploring central manifestations of neuropathy? Angiology. 2014. V. 65(10). P. 857—860. https://doi.org/10.1177/0003319714526971
  139. Waguespack R. W. Congenital Anosmia. Archives of Otolaryngology–Head & Neck Surgery. 1992. V. 118(1). P. 10. https://doi.org/10.1001/archotol.1992.01880010012002
  140. Wakabayashi T., Hidaka R., Fujimaki S., Asashima M., Kuwabara T. Diabetes impairs Wnt3 protein-induced neurogenesis in olfactory bulbs via glutamate transporter 1 inhibition. Journal of Biological Chemistry. 2016. V. 291(29). P. 15196—15211. https://doi.org/10.1074/jbc.M115.672857
  141. Wangberg H., White A. A. Aspirin-exacerbated respiratory disease. Current opinion in immunology. 2020. V. 66. P. 9—13. https://doi.org/10.1016/j.coi.2020.02.006
  142. Weber E. M., Olsson I. A.S. Maternal behaviour in Mus musculus sp.: an ethological review. Applied Animal Behaviour Science. 2008. V. 114(1—2). P. 1—22. https://doi.org/10.1016/j.applanim.2008.06.006
  143. Weinstock R. S., Wright H. N., Smith D. U. Olfactory dysfunction in diabetes mellitus. Physiology & behavior. 1993. V. 53(1). P. 17—21. https://doi.org/10.1016/0031—9384(93)90005-z
  144. Wilson R. S., Arnold S. E., Schneider J. A., Tang Y., Bennett D. A. The relationship between cerebral Alzheimer’s disease pathology and odour identification in old age. Journal of Neurology, Neurosurgery & Psychiatry. 2007. V. 78(1). P. 30—35. https://doi.org/10.1136/jnnp.2006.099721
  145. Witt R. M., Galligan M. M., Despinoy J. R., Segal R. Olfactory behavioral testing in the adult mouse. JoVE (Journal of Visualized Experiments). 2009. V. 23. P. e949. https://doi.org/10.3791/949.
  146. Yahyaeipour H., Ganji F., Sepehri H., Nazari Z. The effect of type 2 diabetes on the olfactory bulb structure of Wistar rats. Nova Biologica Reperta. 2023. V. 10(1). P. 11—16.
  147. Yang J., Pinto J. M. The epidemiology of olfactory disorders. Current otorhinolaryngology reports. 2016. V. 4(2). P. 130—141. https://doi.org/10.1007/s40136—016—0120—6
  148. Yang M., Crawley J. N. Simple behavioral assessment of mouse olfaction. Current protocols in neuroscience. 2009. V. 48(1). P. 8.24.1—8.24.12. https://doi.org/10.1002/0471142301.ns0824s48.
  149. Yu Q., Cai Z., Li C., Xiong Y., Yang Y., He S., Tang H., Zhang B., Du S., Yan H., Chang C., Wang N. A novel Spectrum contrast mapping method for functional magnetic resonance imaging data analysis. Frontiers in Human Neuroscience. 2021. V. 15. P. 739668. https://doi.org/10.3389/fnhum.2021.739668
  150. Zaghloul H., Pallayova M., Al-Nuaimi O., Hovis K. R., Taheri S. Association between diabetes mellitus and olfactory dysfunction: current perspectives and future directions. Diabetic Medicine. 2018. V. 35(1). P. 41—52. https://doi.org/10.1111/dme.13542
  151. Zapiec B., Dieriks B. V., Tan S., Faull R. L. M., Mombaerts P., Curtis M. A. A ventral glomerular deficit in Parkinson’s disease revealed by whole olfactory bulb reconstruction. Brain. 2017. V. 140(10). P. 2722—2736. https://doi.org/10.1093/brain/awx208
  152. Zhang, C., Hara, T. J. Lake char (Salvelinus namaycush) olfactory neurons are highly sensitive and specific to bile acids. J. Comp. Physiol. 2009. A 195. P. 203—215. https://doi.org/10.1007/s00359—008—0399-y
  153. Zhao Y., He Y., He R., Zhou Y., Pan H., Zhou X., Zhu L., Zhou X., Liu Z., Xu Q., Sun Q., Tan J., Yan X., Tang B., Guo J. The discriminative power of different olfactory domains in Parkinson’s disease. Frontiers in neurology. 2020. V. 11. P. 420. https://doi.org/10.3389/fneur.2020.00420
  154. Zheng J., Wong L. R., Li K., Verma A. K., Ortiz M. E., Wohlford-Lenane C., Leidinger M. R., Knudson C. M., Meyerholz D. K., McCray P. B. Jr, Perlman S. COVID-19 treatments and pathogenesis including anosmia in K18-hACE2 mice. Nature. 2021. V. 589. P. 603—607. https://doi.org/10.1038/s41586—020—2943-z
  155. Ziuzia-Januszewska L., Januszewski M. Pathogenesis of olfactory disorders in COVID-19. Brain Sciences. 2022. V. 12(4). P. 449. https://doi.org/10.3390/brainsci12040449.
  156. Zou J., Wang W., Pan Y. W., Lu S., Xia Z. Methods to measure olfactory behavior in mice. Current protocols in toxicology. 2015. V. 63(1). P. 11.18.1—11.18.21. https://doi.org/10.1002/0471140856.tx1118s63.
  157. Zou Y. M., Lu D., Liu L. P., Zhang H. H., Zhou Y. Y. Olfactory dysfunction in Alzheimer’s disease. Neuropsychiatric disease and treatment. 2016. V. 12. P. 869—875. https://doi.org/10.2147/NDT.S104886.

Copyright (c) 2024 Russian Academy of Sciences

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies